Sonya Arreola1, Ricky N Bluthenthal2, Lynn Wenger3, Daniel Chu2, James Thing2, Alex H Kral3. 1. Global Forum on MSM and HIV, 436 14th Street, Suite 1500, Oakland, CA 94612, United States. Electronic address: ArreolaResearch@gmail.com. 2. Department of Preventive Medicine, Institute for Prevention Research, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States. 3. Urban Health Program, RTI International, 351 California St., San Francisco, CA 94104, United States.
Abstract
BACKGROUND: Studies report that among people who inject drugs (PWID), approximately 1 in 7 initiated injection during their thirties or later (referred to hereafter as "late initiates"). However, little is known about individuals who are late initiates. This study aims to describe characteristics of late initiates to drug injection and to examine how they differ from people who initiated drug injection prior to the age of 30 ("typical initiates"). METHODS: We recruited 696 active PWID in Los Angeles and San Francisco, California between 2011 and 2013, using targeted sampling and street outreach methods. Participants completed personal interviews that covered items on demographics, drug use history and practices, injection initiation episode, HIV injection- and sex-related risk, health care utilization among others. We used bivariate and multivariate analyses to examine factors associated being a late initiate. RESULTS: In our sample, 19% of participants who were 30 years or older were classified as late initiates. In multivariate analysis controlling for city, late initiates had higher odds of being female and African American, having been in treatment prior to initiation, initiating illicit drug use at an older age, and being assisted into injection by someone of the same age or younger. Late initiates had lower odds of frequent recent injection, and having a bipolar disorder diagnosis. CONCLUSION: Late initiates comprise a significant proportion of active PWIDs. More study on the health consequences of late initiation are needed as are interventions to prevent transition to drug injection among at-risk populations.
BACKGROUND: Studies report that among people who inject drugs (PWID), approximately 1 in 7 initiated injection during their thirties or later (referred to hereafter as "late initiates"). However, little is known about individuals who are late initiates. This study aims to describe characteristics of late initiates to drug injection and to examine how they differ from people who initiated drug injection prior to the age of 30 ("typical initiates"). METHODS: We recruited 696 active PWID in Los Angeles and San Francisco, California between 2011 and 2013, using targeted sampling and street outreach methods. Participants completed personal interviews that covered items on demographics, drug use history and practices, injection initiation episode, HIV injection- and sex-related risk, health care utilization among others. We used bivariate and multivariate analyses to examine factors associated being a late initiate. RESULTS: In our sample, 19% of participants who were 30 years or older were classified as late initiates. In multivariate analysis controlling for city, late initiates had higher odds of being female and African American, having been in treatment prior to initiation, initiating illicit drug use at an older age, and being assisted into injection by someone of the same age or younger. Late initiates had lower odds of frequent recent injection, and having a bipolar disorder diagnosis. CONCLUSION: Late initiates comprise a significant proportion of active PWIDs. More study on the health consequences of late initiation are needed as are interventions to prevent transition to drug injection among at-risk populations.
Authors: Vera Frajzyngier; Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Samuel R Friedman Journal: Drug Alcohol Depend Date: 2007-02-05 Impact factor: 4.492
Authors: M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis Journal: N Engl J Med Date: 1999-08-19 Impact factor: 91.245
Authors: Cari L Miller; Margo E Pearce; Akm Moniruzzaman; Vicky Thomas; Wayne Christian; Martin T Schechter; Patricia M Spittal Journal: CMAJ Date: 2011-06-13 Impact factor: 8.262
Authors: Melissa R Pfeiffer; David B Hanna; Elizabeth M Begier; Kent A Sepkowitz; Regina Zimmerman; Judith E Sackoff Journal: Subst Use Misuse Date: 2011 Impact factor: 2.164
Authors: David Vlahov; Cun-Lin Wang; Noya Galai; Joseph Bareta; Shruti H Mehta; Steffanie A Strathdee; Kenrad E Nelson Journal: Addiction Date: 2004-08 Impact factor: 6.526
Authors: David Vlahov; Cunlin Wang; Danielle Ompad; Crystal M Fuller; Wendy Caceres; Lawrence Ouellet; Peter Kerndt; Don C Des Jarlais; Richard S Garfein Journal: Subst Use Misuse Date: 2008 Impact factor: 2.164
Authors: Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral Journal: Drug Alcohol Depend Date: 2017-04-19 Impact factor: 4.492
Authors: Stephanie R Dyal; Alex H Kral; Karina Dominguez Gonzalez; Lynn D Wenger; Ricky N Bluthenthal Journal: Am J Drug Alcohol Abuse Date: 2015-05-13 Impact factor: 3.829
Authors: Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Jennifer Lorvick; Brendan Quinn; James P Thing; Alex H Kral Journal: Drug Alcohol Depend Date: 2015-02-19 Impact factor: 4.492
Authors: Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Brendan Quinn; James Thing; Alex H Kral Journal: Drug Alcohol Depend Date: 2014-09-18 Impact factor: 4.492
Authors: Ricky N Bluthenthal; Daniel Chu; Lynn D Wenger; Philippe Bourgois; Thomas Valente; Alex H Kral Journal: Drug Alcohol Depend Date: 2018-02-15 Impact factor: 4.492